Daniel Schmutz joins the Board of Directors of AXA Switzerland. He succeeds Max E. Katz, who is retiring from the board upon reaching retirement age.
Daniel Schmutz has been elected to the Board of Directors of AXA Switzerland as of April 17, 2025. The 59-year-old is the founder of the consulting firm DS Advisory GmbH, which holds various mandates in the insurance and healthcare sectors. Prior to that, he served as CEO of Helsana for around 11 years and, before that, as CFO for four and a half years. Previous professional positions include three years at Swiss Life Holding, where Daniel Schmutz was Head of Group Strategy and Controlling, and around five years at the Boston Consulting Group. Before that, he worked as a consultant for the LEK/Alcar Group in Germany and the USA. His educational background includes a degree in international relations from the University of St. Gallen and a master’s degree in finance from the Wharton School in Philadelphia. A Swiss citizen, he is married with two children and lives in Küsnacht.
“With his many years of experience in strategic and financial matters, as well as his profound knowledge of the insurance and healthcare industries, Daniel Schmutz will certainly be a valuable addition to our Board of Directors. I am therefore delighted that we have been able to secure his appointment and wish him much satisfaction in his new role,” says Chairman of the Board of Directors Antimo Perretta.
Resignation of Max E. Katz
Daniel Schmutz succeeds Max E. Katz, who is stepping down after nine years on the Board of Directors of AXA Switzerland due to age. “With his in-depth financial expertise and extensive experience in dealing with challenging situations, Max E. Katz was a very important and valued voice within our organization. We will miss his constructive and appreciative approach. I sincerely thank Max for his great contributions to AXA Switzerland and wish him all the best for the future,” said Chairman of the Board of Directors Antimo Perretta.
The elections are subject to the applicable regulatory requirements.
Source